 |
Directeur, Programme d'évaluation, d'intervention et de prévention des psychoses (PEPP-Montréal), Institut Douglas
ashok_dot_malla_At_douglas_dot_mcgill_dot_ca |
2006
Goldberg K., Norman R., Hoch J., Schmitz N., Windell D., Brown T., Malla A. (2006). Impact of a specialized early intervention service for psychotic disorders on patient characteristics, service use, and hospital costs in a defined catchment area, Can J Psychiatry, 51(14), 895-903.
Jensen J. E., Miller J., Williamson P. C., Neufeld R. W., Menon R. S., Malla A., Manchanda R., Schaefer B., Densmore M., Drost D. J. (2006). Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla, Psychiatry Res, 146(2), 127-35.
Joober R., Schmitz N., Malla A., Sengupta S., Karma S. (2006). Is olanzapine a brain-sparing medication?, Arch Gen Psychiatry, 63(11), 1292.
Kopala L., Smith G., Malla A., Williams S., Love L., Talling D., Balshaw R. (2006). Resource utilization in a Canadian national study of people with schizophrenia and related psychotic disorders, Acta Psychiatr Scand Suppl(430), 29-39.
Malla A., Norman R. (2006). Preface, Acta Psychiatr Scand Suppl(430), 3.
Malla A., Norman R., Schmitz N., Manchanda R., Bechard-Evans L., Takhar J., Haricharan R. (2006). Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study, Psychol Med, 1-10.
Malla A., Williams S., Kopala L., Smith G., Talling D., Balshaw R. (2006). Outcome on quality of life in a Canadian national sample of patients with schizophrenia and related psychotic disorders, Acta Psychiatr Scand Suppl(430), 22-8.
Payne J., Malla A., Norman R., Windell D., Nicole B. (2006). Status of first-episode psychosis patients presenting for routine care in a defined catchment area, Can J Psychiatry, 51(1), 42-7.
Smith G., Malla A., Williams S., Kopala L., Love L., Balshaw R. (2006). The Canadian National Outcomes Measurement Study in Schizophrenia: overview of the patient sample and methodology, Acta Psychiatr Scand Suppl(430), 4-11.
Williams S., Kopala L., Malla A., Smith G., Love L., Balshaw R. (2006). Medication decisions and clinical outcomes in the Canadian National Outcomes Measurement Study in Schizophrenia, Acta Psychiatr Scand Suppl(430), 12-21.
